Use of granulocyte colony-stimulating factor in ART treatment does not increase the risk of adverse perinatal outcomes

ConclusionsAdministration of G-CSF at embryo transfer and during early pregnancy in recurrent miscarriage patients with KIR-HLA-C mismatch undergoing egg donation ART treatment does not convey a higher risk of perinatal complications compared with control women undergoing ART treatment.
Source: Reproductive BioMedicine Online - Category: Reproduction Medicine Source Type: research